AJOONI

Ajooni Biotech Share Price

 

 

Start SIP in AJOONI

Start SIP
Ajooni Biotech live price: ₹4.05. It opened at ₹4 vs previous close ₹4; intraday high/low: ₹4/₹4. The 50 & 200 DMA stand at ₹4.34/₹4.93.

Ajooni Biotech Performance

  • Today's Low
  • ₹4
  • Today's High
  • ₹4
  • 52 Week Low
  • ₹4
  • 52 Week High
  • ₹7
  • Open Price₹4
  • Previous Close₹4
  • Volume339,708
  • 50 DMA₹4.34
  • 100 DMA₹4.52
  • 200 DMA₹4.93

Investment Returns

  • Over 1 Month + 1.25%
  • Over 3 Month -6.47%
  • Over 6 Month -23%
  • Over 1 Year -32.27%

Smart Investing Starts Here Start SIP with Ajooni Biotech for Steady Growth!

Invest Now

Ajooni Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.2
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 70
  • P/B Ratio
  • 0.8
  • Average True Range
  • 0.25
  • EPS
  • 0.28
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.12
  • RSI
  • 44.33
  • MFI
  • 40.86

Ajooni Biotech Financials

Ajooni Biotech Technicals

EMA & SMA

Current Price
₹4.05
-0.06 (-1.46%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹4.17
  • 50 Day
  • ₹4.34
  • 100 Day
  • ₹4.52
  • 200 Day
  • ₹4.93

Resistance and Support

4.05 Pivot Speed
  • R3 4.21
  • R2 4.16
  • R1 4.10
  • S1 3.99
  • S2 3.94
  • S3 3.88

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ajooni Biotech has an operating revenue of Rs. 151.03 Cr. on a trailing 12-month basis. An annual revenue growth of 42% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 26% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 43 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 5 indicates it belongs to a strong industry group of Agricultural Operations and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ajooni Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-30 Quarterly Results & Others To consider other business matters issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-.
2025-11-13 Quarterly Results
2025-08-29 Others To consider other business matters issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-.
2025-08-14 Quarterly Results & Others To consider other business matters issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-.
2025-02-13 Quarterly Results
Date Purpose Remarks
2022-10-07 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Ajooni Biotech F&O

Ajooni Biotech Shareholding Pattern

26.89%
65.91%
7.2%

Ajooni Biotech FAQs

Ajooni Biotech share price is ₹4 As on 03 April, 2026 | 22:23

The Market Cap of Ajooni Biotech is ₹69.8 Cr As on 03 April, 2026 | 22:23

The P/E ratio of Ajooni Biotech is 14.2 As on 03 April, 2026 | 22:23

The PB ratio of Ajooni Biotech is 0.8 As on 03 April, 2026 | 22:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23